Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MANUEL J PARDO

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1366699423
CMS profile
106884
Location
ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$11,341.00

155 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 4 of 4; records 151–155 of 155 matching records. This page contains 5 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MANUEL J PARDO

NPI 1366699423 · CMS profile ID 106884

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

ORANGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–155 of 155 matching records. This page contains 5 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1366699423?year=2019&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MANUEL J PARDO, NPI 1366699423, CMS profile ID 106884. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–155 of 155 matching records. This page contains 5 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1366699423?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MANUEL J PARDO, NPI 1366699423, CMS profile ID 106884. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–155 of 155 matching records. This page contains 5 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1366699423?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MANUEL J PARDO, NPI 1366699423, CMS profile ID 106884, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–155 of 155 matching records. This page contains 5 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1366699423?year=2019&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

155 matching records · $11,341.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 155 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–155 of 155.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme Corporation $19.4701/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695227043 CMS
Janssen Biotech, Inc. $14.1101/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658632398 CMS
Gilead Sciences, Inc. $18.6401/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681579309 CMS
Gilead Sciences, Inc. $23.1901/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681579307 CMS
ViiV Healthcare Company $18.9001/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671608959 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,341.00 155
PY2020 $4,752.18 72
PY2021 $5,671.37 75
PY2022 $5,652.69 71
PY2023 $30,045.86 134
PY2024 $56,245.16 191
PY2025 $35,419.00 129

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $257,359.44 38

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

38 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Gilead Sciences, Inc. $1,864.00 12/16/2025 Non-covered Recipient Entity
ANTHONY M MILLS MD INC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217108
Principal investigator 1 Gilead Sciences, Inc. $2,034.00 12/09/2025 Non-covered Recipient Entity
ANTHONY M MILLS MD INC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217101
Principal investigator 1 ViiV Healthcare Company $4,736.51 11/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319373
Principal investigator 1 ViiV Healthcare Company $525.00 11/21/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319299
Principal investigator 1 ViiV Healthcare Company $202.64 11/21/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319375
Principal investigator 1 ViiV Healthcare Company $15,154.52 11/19/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319361
Principal investigator 1 Gilead Sciences, Inc. $2,940.00 11/18/2025 Non-covered Recipient Entity
ANTHONY M MILLS MD INC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217093
Principal investigator 1 ViiV Healthcare Company $462.00 11/05/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319297
Principal investigator 1 ViiV Healthcare Company $735.00 11/05/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319309
Principal investigator 1 ViiV Healthcare Company $238.00 11/05/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319369
Principal investigator 1 ViiV Healthcare Company $380.59 11/05/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319417
Principal investigator 1 Gilead Sciences, Inc. $109,114.00 11/04/2025 Non-covered Recipient Entity
ANTHONY M MILLS MD INC
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229217084
Principal investigator 1 ViiV Healthcare Company $14,837.30 10/28/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319405
Principal investigator 1 ViiV Healthcare Company $5,154.58 10/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319365
Principal investigator 1 ViiV Healthcare Company $11,120.89 10/02/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319301
Principal investigator 1 ViiV Healthcare Company $6,849.86 09/29/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319223
Principal investigator 1 ViiV Healthcare Company $10,889.28 09/23/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319413
Principal investigator 1 ViiV Healthcare Company $87.00 09/15/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319363
Principal investigator 1 ViiV Healthcare Company $175.00 08/26/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317221
Principal investigator 1 ViiV Healthcare Company $1,000.00 08/26/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317223
Principal investigator 1 ViiV Healthcare Company $18,870.56 08/15/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317219
Principal investigator 1 ViiV Healthcare Company $700.00 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317217
Principal investigator 1 ViiV Healthcare Company $350.00 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317225
Principal investigator 1 ViiV Healthcare Company $201.53 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319215
Principal investigator 1 ViiV Healthcare Company $250.00 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319217
Principal investigator 1 ViiV Healthcare Company $142.78 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319219
Principal investigator 1 ViiV Healthcare Company $500.00 08/04/2025 Non-covered Recipient Entity
ANTHONY MILLS-LOS ANGELES-UNITED STATES-
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319221
Principal investigator 1 ViiV Healthcare Company $500.00 07/30/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319305
Principal investigator 1 ViiV Healthcare Company $12,350.55 07/29/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319415
Principal investigator 1 ViiV Healthcare Company $139.63 07/28/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319303
Principal investigator 1 ViiV Healthcare Company $525.00 07/28/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319311
Principal investigator 1 ViiV Healthcare Company $29,908.76 07/22/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319227
Principal investigator 1 ViiV Healthcare Company $2,500.00 07/10/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319371
Principal investigator 1 ViiV Healthcare Company $92.40 06/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319225
Principal investigator 1 ViiV Healthcare Company $92.40 06/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319307
Principal investigator 1 ViiV Healthcare Company $184.80 06/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319367
Principal investigator 1 ViiV Healthcare Company $92.40 06/24/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319403
Principal investigator 1 ViiV Healthcare Company $1,458.46 06/23/2025 Non-covered Recipient Entity
ANTHONY MILLS MD
A PHASE 3B, OPEN LABEL, RANDOMIZED, STANDARD-OF-CARE CONTROL ARM, MULT No dispute reported 06/30/2026 1190319229